期刊
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
卷 91, 期 3, 页码 367-373出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.pbb.2008.08.008
关键词
Cisplatin; Emesis; Antiemetic; Delta-9-THC; Tropisetron; Dexamethasone
资金
- NIH [R01CA115331]
- NATIONAL CANCER INSTITUTE [R01CA115331] Funding Source: NIH RePORTER
5-HT3 receptor antagonists (e.g. tropisetron) combined with dexamethasone are effective for the acute phase of cisplatin (CIS)-induced emesis. This Study determined the possible additive or synergistic antiemetic efficacy of Delta(9)-THC when combined with tropisetron or dexamethasone (DEX). Delta(9)-THC (0-10 mg/kg i.p.) was injected in combination with tropisetron (0-5 mg/kg i.p.) or dexamethasone (0-20 mg/kg i.p.) prior to CIS (20 mg/kg i.p.) in the least shrew, and the induced emesis was recorded for 60 min. CIS-induced vomiting was dose-dependently and significantly attenuated by individual administration of Delta(9)-THC (59-97% reductions) and tropisetron (79-100% attenuation), but not dexamethasone (26-40%), although a trend (p < 0.1) towards reduced vomiting frequency following DEX was noted. Low doses of Delta(9)-THC (0.25 or 0.5 mg/kg) when combined with low doses of tropisetron (0.025, 0.1, or 0.25 mg/kg) were more efficacious in reducing emesis frequency than when given individually, but Delta(9)-THC had no antiemetic interactions with DEX. However, no tested combination provided a significantly greater effect on the number of animals vomiting than their individually-administered counterparts. The modest interaction of Delta(9)-THC with tropisetron suggests they activate overlapping antiemetic mechanisms, while the lack of interaction with dexamethasone needs further clarification. (c) 2008 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据